Multimodal Augmented Reality for Operative Guidance in Interventional Neuroradiology
| ISRCTN | ISRCTN90482012 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN90482012 |
| IRAS number | 319189 |
| Secondary identifying numbers | CPMS 54208 |
- Submission date
- 14/08/2024
- Registration date
- 03/09/2024
- Last edited
- 16/05/2025
- Recruitment status
- Recruiting
- Overall study status
- Deferred
- Condition category
- Other
Plain English summary of protocol
The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
Contact information
Principal Investigator
Imperial College Healthcare NHS Trust
Charing Cross Hospital
Fulham Palace Road
London
W6 8RF
United Kingdom
 ORCID ID |
0000-0001-5093-9751 |
|---|---|
| k.lobotesis@nhs.net |
Public, Scientific
Medical iSight (UK) Ltd
9th Floor
107 Cheapside
London
EC2V 6DN
United Kingdom
| pjp@medicalisight.com |
Study information
| Study design | Single-centre interventional trial in patients undergoing interventional neuroradiology procedures |
|---|---|
| Primary study design | Interventional |
| Secondary study design | |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Participant information sheet | Not available in web format |
| Scientific title | Multimodal Augmented Reality for Operative Guidance in Interventional Neuroradiology |
| Study acronym | MAROG-INR |
| Study objectives | The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Ethics approval(s) |
Approved 21/02/2023, London - Dulwich Research Ethics Committee (Skipton House, 80 London Road, London, SE1 6LH, United Kingdom; +44 (0)207 104 8290; dulwich.rec@hra.nhs.uk), ref: 23/LO/0030 |
| Health condition(s) or problem(s) studied | The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Intervention | The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Intervention type | Other |
| Primary outcome measure | The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Secondary outcome measures | The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Overall study start date | 29/11/2022 |
| Completion date | 01/07/2026 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 50 |
| Key inclusion criteria | The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Key exclusion criteria | The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended. |
| Date of first enrolment | 01/09/2024 |
| Date of final enrolment | 01/04/2026 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
London
W6 8RF
United Kingdom
Sponsor information
Industry
9th Floor
107 Cheapside
London
EC2V 6DN
England
United Kingdom
| pjp@medicalisight.com | |
| Website | https://www.medicalisight.com/ |
Funders
Funder type
Other
No information available
Results and Publications
| Intention to publish date | 21/02/2026 |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not expected to be made available |
| Publication and dissemination plan | Full trial details will be published up to 30 months after the end of the trial. Results will be posted on or after the date of publication of full trial details. |
| IPD sharing plan | The datasets generated and/or analysed during the current study are not expected to be made available because of their high commercial sensitivity and the negligible benefit to the public of publication of results of non-therapeutic clinical trials. |
Editorial Notes
16/05/2025: The recruitment end date was changed from 21/02/2025 to 01/04/2026.
14/05/2025: The overall end date was changed from 21/02/2025 to 01/07/2026.
08/10/2024: Internal review.
15/08/2024: Study's existence confirmed by the HRA.
